Panimus Integration

Panimus Integration

Share

Paul Antico: Rosen Method Bodywork, Compassionate Inquiry Practitioner. PSIP, Psychedelic Integration & Support. This happens monthly.

I am privileged to be your guide on the often challenging but rewarding journey of healing. I recognize your essence underneath the issues, and support your connection with your own essence-tial self. Gabor Maté’s Compassionate Inquiry is an elegant somatic based system that supports understanding, growth and healing, providing insight through direct experience. As a Certified CI Practitioner, I s

Trainees Unprepared for Advances in Psychedelic Medicine: A Survey Study 04/27/2024

Choose your facilitators wisely!
Are medical trainees ready for psychedelics?

With the U.S. Food and Drug Administration months away from deciding whether MDMA-assisted therapy should be approved for medical use in treating PTSD, and more states considering regulated psychedelic programs, there could soon be heightened demand for psychedelic-assisted therapy. But according to data published in The Journal of Psychoactive Drugs this week, medical trainees are “unprepared for advances in psychedelic medicine.” Researchers at the University of Michigan, Wayne State, and SUNY Buffalo analyzed survey results from over 200 trainees in programs in medicine, pharmacy, psychology, social work, and biological science. Only 10 percent reported receiving any training in psychedelic medicine or psychotherapy, and most reported that their knowledge about psychedelics came from word of mouth, social media, or popular media.

Participants were also asked 12 questions to assess their knowledge of psychedelics. Questions included, “What is the main psychoactive ingredient in ayahuasca?” and “Under which category are psychedelic drugs scheduled in the United States?” Over a quarter of participants answered none of the questions correctly, and the average score was 31 percent. “The survey indicated that overall knowledge surrounding psychedelic science and medicine is quite low,” the authors wrote. In considering these results alongside another recent study showing that nearly 80 percent of psychiatrists said they’d been asked about psychedelic-assisted therapies by patients or families, the researchers note that a lack of knowledge could stymie the development of psychedelic therapies. “Lack of adequate knowledge among trainees carries the risk of creating biases and prejudices against these novel treatments and could result in a decreased number of adequately trained medical professionals who are able to carry out psychedelic-assisted therapies,” they write.

Trainees Unprepared for Advances in Psychedelic Medicine: A Survey Study This study aimed to characterize attitudes and identify gaps in trainee knowledge and education that may impact the field’s readiness for the reemergence of psychedelic use in psychiatry. A two-par...

03/29/2024

Psychedelic comedian Shane Mauss live in Los Angeles! Five dollars off tickets use code GPS Global Psychedelic Society

03/21/2024

From Psychedelic Alpha:

Whole Mushroom vs. Synthetic Psilocybin

Scottsdale Research Institute’s Sue Sisley gave two talks at SXSW. In both appearances, Sisley was keen to highlight the fact that clinical research into psychedelics has neglected to study whole-mushroom psilocybin, instead opting to investigate synthetic preparations of the drug.

When psilocybin is ingested as part of the whole mushroom it’s naturally found in, Sisley said, ‘all the molecules work in concert with each other’ to achieve a ‘natural balance’. The researcher has made it her mission to run such studies.

And it looks like she might be about to do so: Sisley shared that her group at the Scottsdale Research Institute has been awarded $2.75m from Arizona state funding for a Phase I study of whole psilocybin mushrooms in patients with life-threatening diseases.

While the study will primarily be geared towards assessing safety, Sisley and co. will try to get an early read on the mushrooms’ anxiolytic potential. You can read more about the project by reviewing the grant documents.

Sisley acknowledged that it would be tough to get whole mushroom preparations past Phase I, given GMP requirements. But it’s certainly an interesting study, especially given the provision of state funding.

Shortly before SXSW, a paper from the Hadassah BrainLabs Center for Psychedelic Research was published in Molecular Psychiatry (Shahar et al., 2024). The researchers sought to compare the effects of chemically synthesized psilocybin (provided by Usona Institute) with whole mushroom extract in mice.

The researchers concluded that psilocybin mushroom extract “has a more potent and prolonged effect on synaptic plasticity” than synthetic psilocybin. While they acknowledge further studies are needed, the authors’ contribution makes a compelling case for more exploration of the polypharmacology or ‘entourage effect’ of mushrooms.

Want your business to be the top-listed Gym/sports Facility in South Los Angeles?

Click here to claim your Sponsored Listing.

Address


South Los Angeles, CA
90015